Jeffrey A.  Munsie net worth and biography

Jeffrey Munsie Biography and Net Worth

Mr. Jeffrey A. Munsie has served as our Chief Legal Officer since September 2019. Prior to joining Concert Mr. Munsie served as Senior Vice President, General Counsel and Head of Corporate Operations at Merrimack Pharmaceuticals, a biopharmaceutical company, from 2011 to 2019. Prior to Merrimack, he was a member of the corporate department at the law firm Wilmer Cutler Pickering Hale and Dorr in Boston from 2002 to 2011. Mr. Munsie received a J.D. from Harvard Law School and a B.A. from Dartmouth College.

What is Jeffrey A. Munsie's net worth?

The estimated net worth of Jeffrey A. Munsie is at least $736,970.13 as of February 15th, 2023. Mr. Munsie owns 88,049 shares of Concert Pharmaceuticals stock worth more than $736,970 as of March 29th. This net worth evaluation does not reflect any other assets that Mr. Munsie may own. Learn More about Jeffrey A. Munsie's net worth.

How do I contact Jeffrey A. Munsie?

The corporate mailing address for Mr. Munsie and other Concert Pharmaceuticals executives is 65 HAYDEN AVENUE SUITE 3000N, LEXINGTON MA, 02421. Concert Pharmaceuticals can also be reached via phone at (781) 860-0045 and via email at [email protected]. Learn More on Jeffrey A. Munsie's contact information.

Has Jeffrey A. Munsie been buying or selling shares of Concert Pharmaceuticals?

Jeffrey A. Munsie has not been actively trading shares of Concert Pharmaceuticals during the past quarter. Most recently, Jeffrey A. Munsie sold 3,762 shares of the business's stock in a transaction on Wednesday, February 15th. The shares were sold at an average price of $8.34, for a transaction totalling $31,375.08. Following the completion of the sale, the insider now directly owns 88,049 shares of the company's stock, valued at $734,328.66. Learn More on Jeffrey A. Munsie's trading history.

Who are Concert Pharmaceuticals' active insiders?

Concert Pharmaceuticals' insider roster includes Marc Becker (CFO), James Cassella (Insider), Jeffrey Munsie (Insider), Nancy Stuart (COO), and Roger Tung (CEO). Learn More on Concert Pharmaceuticals' active insiders.

Jeffrey A. Munsie Insider Trading History at Concert Pharmaceuticals

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/15/2023Sell3,762$8.34$31,375.0888,049View SEC Filing Icon  
1/30/2023Sell8,493$8.35$70,916.5591,811View SEC Filing Icon  
2/14/2022Sell3,762$3.09$11,624.58View SEC Filing Icon  
2/16/2021Sell3,763$7.32$27,545.1646,153View SEC Filing Icon  
See Full Table

Jeffrey A. Munsie Buying and Selling Activity at Concert Pharmaceuticals

This chart shows Jeffrey A Munsie's buying and selling at Concert Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Concert Pharmaceuticals Company Overview

Concert Pharmaceuticals logo
Concert Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which discovers and develops novel small molecule drugs through the use of deuterium technology. Its product candidates target a range of diseases including autoimmune disorders, inflammation, and central nervous system disorders. The company was founded by Richard H. Aldrich, Roger D. Tung and Christoph H. Westphal on April 12, 2006 and is headquartered in Lexington, MA.
Read More

Today's Range

Now: $8.37
Low: $8.37
High: $8.37

50 Day Range

MA: $8.37
Low: $8.33
High: $8.40

2 Week Range

Now: $8.37
Low: $2.66
High: $8.55

Volume

N/A

Average Volume

2,970,800 shs

Market Capitalization

$401.26 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.52